Koji Torii

发表

Effectiveness of plasma treatment on pancreatic cancer cells

M. Kanda, S. Yamada, T. Fujii, 2015, International journal of oncology.

Phase II multi-institutional prospective trial of nab-paclitaxel as second-line chemotherapy for advanced gastric cancer refractory to fluoropyrimidine with modified dose reduction criteria (CCOG1303)

Y. Kodera, M. Ando, D. Kobayashi, 2020, International Journal of Clinical Oncology.